About Allinaire Therapeutics
Allinaire Therapeutics is a private company based in Cleveland, Ohio. It has reported $700,000 raised in one offering on Form D since April 2026. Its chief executive is Douglas Hay.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 30, 2026 | Apr 14, 2026 | $700,000fully sold | 2 | $350K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Allinaire Therapeutics's Form D filed Apr 14, 2026.